These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26118191)

  • 21. Allele-specific amplification of exon 7 in the survival motor neuron (SMN) genes for molecular diagnosis of spinal muscular atrophy.
    Simsek M; Al-Bulushi T; Shanmugakonar M; Al-Barwani HS; Bayoumi R
    Genet Test; 2003; 7(4):325-7. PubMed ID: 15000810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Universal multiplex PCR and CE for quantification of SMN1/SMN2 genes in spinal muscular atrophy.
    Wang CC; Chang JG; Jong YJ; Wu SM
    Electrophoresis; 2009 Apr; 30(7):1102-10. PubMed ID: 19373809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. False homozygous deletions of SMN1 exon 7 using Dra I PCR-RFLP caused by a novel mutation in spinal muscular atrophy.
    Kang SH; Cho SI; Chae JH; Chung KN; Ra EK; Kim SY; Seong MW; Kim JY; Park SS
    Genet Test Mol Biomarkers; 2009 Aug; 13(4):511-3. PubMed ID: 19663601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incorporating Spinal Muscular Atrophy Analysis by Next-Generation Sequencing into a Comprehensive Multigene Panel for Neuromuscular Disorders.
    Tan CA; Westbrook MJ; Truty R; Kvitek DJ; Kennemer M; Winder TL; Shieh PB
    Genet Test Mol Biomarkers; 2020 Oct; 24(10):616-624. PubMed ID: 32721234
    [No Abstract]   [Full Text] [Related]  

  • 25. Diagnosis of Spinal Muscular Atrophy: A Simple Method for Quantifying the Relative Amount of Survival Motor Neuron Gene 1/2 Using Sanger DNA Sequencing.
    Cao YY; Zhang WH; Qu YJ; Bai JL; Jin YW; Wang H; Song F
    Chin Med J (Engl); 2018 Dec; 131(24):2921-2929. PubMed ID: 30539904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of Spinal Muscular Atrophy Patients Using Dried Saliva Spots.
    Wijaya YOS; Nishio H; Niba ETE; Okamoto K; Shintaku H; Takeshima Y; Saito T; Shinohara M; Awano H
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mutation analysis of SMN1 gene in patients with spinal muscular atrophy].
    DU J; Qu YJ; Xiong H; Li EZ; Jin YW; Bai JL; Wang H; Song F
    Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):411-5. PubMed ID: 21924051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of homozygous deletions in spinal muscular atrophy with genomic DNA sequencing].
    Cao YY; Qu YJ; Song F; Bai JL; Jin YW; Wang H; Li Y; Zhang WH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Aug; 30(4):410-4. PubMed ID: 23926006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spinal muscular atrophy carrier screening by multiplex polymerase chain reaction using dried blood spot on filter paper.
    Majumdar R; Rehana Z; Al Jumah M; Fetaini N
    Ann Hum Genet; 2005 Mar; 69(Pt 2):216-21. PubMed ID: 15720302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intragenic mutations in SMN1 may contribute more significantly to clinical severity than SMN2 copy numbers in some spinal muscular atrophy (SMA) patients.
    Yamamoto T; Sato H; Lai PS; Nurputra DK; Harahap NI; Morikawa S; Nishimura N; Kurashige T; Ohshita T; Nakajima H; Yamada H; Nishida Y; Toda S; Takanashi J; Takeuchi A; Tohyama Y; Kubo Y; Saito K; Takeshima Y; Matsuo M; Nishio H
    Brain Dev; 2014 Nov; 36(10):914-20. PubMed ID: 24359787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trinucleotide insertion in the SMN2 promoter may not be related to the clinical phenotype of SMA.
    Harahap NI; Takeuchi A; Yusoff S; Tominaga K; Okinaga T; Kitai Y; Takarada T; Kubo Y; Saito K; Sa'adah N; Nurputra DK; Nishimura N; Saito T; Nishio H
    Brain Dev; 2015 Aug; 37(7):669-76. PubMed ID: 25459970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic testing and risk assessment for spinal muscular atrophy (SMA).
    Ogino S; Wilson RB
    Hum Genet; 2002 Dec; 111(6):477-500. PubMed ID: 12436240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prenatal diagnosis of 5 fetuses with high risk of developing spinal muscular atrophy].
    Lan FH; Zeng J; Huang HJ; Ke LF; Tu XD; Huang LH; Li HZ; Zheng DZ; Yang BS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):373-7. PubMed ID: 17680523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quantitative analysis of the genes determining spinal muscular atrophy].
    Nagymihály M; Herczegfalvi A; Tímár L; Karcagi V
    Ideggyogy Sz; 2009 Nov; 62(11-12):390-7. PubMed ID: 20025129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular analysis and prenatal prediction of spinal muscular atrophy in Chinese patients by the combination of restriction fragment length polymorphism analysis, denaturing high-performance liquid chromatography, and linkage analysis.
    Chen WJ; Wu ZY; Lin MT; Su JF; Lin Y; Murong SX; Wang N
    Arch Neurol; 2007 Feb; 64(2):225-31. PubMed ID: 17296838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newborn blood spot screening test using multiplexed real-time PCR to simultaneously screen for spinal muscular atrophy and severe combined immunodeficiency.
    Taylor JL; Lee FK; Yazdanpanah GK; Staropoli JF; Liu M; Carulli JP; Sun C; Dobrowolski SF; Hannon WH; Vogt RF
    Clin Chem; 2015 Feb; 61(2):412-9. PubMed ID: 25502182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new method for SMN1 and hybrid SMN gene analysis in spinal muscular atrophy using long-range PCR followed by sequencing.
    Kubo Y; Nishio H; Saito K
    J Hum Genet; 2015 May; 60(5):233-9. PubMed ID: 25716911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of PCR-RFLP with allele-specific PCR in genetic testing for spinal muscular atrophy.
    Xu R; Ogino S; Lip V; Fang H; Wu BL
    Genet Test; 2003; 7(4):277-81. PubMed ID: 15000803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of a molecular diagnostic system for spinal muscular atrophy experience from a clinical laboratory in china.
    Zeng J; Lin Y; Yan A; Ke L; Zhu Z; Lan F
    J Mol Diagn; 2011 Jan; 13(1):41-7. PubMed ID: 21227393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of SMA screening kits with SMN1 gene analysis in a Turkish cohort.
    Gülşen M; Ceylan AC; Bahsi T; Çubukçu HC; Dursun OB
    Clin Chim Acta; 2024 Mar; 555():117793. PubMed ID: 38309554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.